Page 50 - Read Online

Yapali et al. Hepatoma Res 2018;4:24 I http://dx.doi.org/10.20517/2394-5079.2018.57 Page 9 of 10

oral antiviral therapy retain a higher risk for HCC compared to inactive stage patients. Gut 2014;63:1943-50.
26. Sánchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodés J. Influence of hepatitis B virus genotype on the long-term outcome of chronic
hepatitis B in western patients. Gastroenterology 2002;123:1848-56.
27. Sumi H, Yokosuka O, Seki N, Aral M, Imazeki F, Kurihara T, Kanda T, Fuaki K, Kato M, Saisho H. Influence of hepatitis B virus
genotypes on the progression of chronic type B liver disease. Hepatology 2003;37:19-26.
28. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ. Hepatitis B virus genotype and DNA level
and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005;97:265-72.
29. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, Kaymakoglu S, Ergonul O. Seroprevalance of hepatitis B and C
virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 2015;21:1020-6.
30. Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, Saadat A, Sofian M, Adibi L, Irani N, Mehryar M, Akbari HMH, Purkhayat
SMJ, Ramezani A. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma. Int J Infect Dis 2009;13:685-9.
31. Baig S, Siddiqui AA, Ahmed W, Qureshi H, Arif A. The association of complex liver disorders with HBV genotypes prevalent in
Pakistan. Virol J 2007;4:128.
32. Abdo AA, Al-Jarallah BM, Sanai FM, Hersi AS, Al-Swat K, Azzam NA, Al-Dukhayil M, Al-Maarik A, Al-Faleh FZ. Hepatitis B
genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia. World J Gastroenterol 2006;12:7019-24.
33. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, Azizi M, Mahboudi F. Complete genomic sequence and
phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol 2005;76:318-26.
34. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Mahboudi F, Sabahi F, Adeli A, Noorinayer B, Azizi M, Reza Zali M. Genotype
characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients. J Med Virol 2005;75:227-34.
35. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, Seddigghi N, Mohamadnejad M, Sotoudeh
M, Madjlessi A. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J
Gastroenterol Hepatol 2005;20:229-33.
36. Jahani MR, Motevalian SA, Mahmoodi M. Hepatitis B carriers in large vehicle drivers of Iran. Vaccine 2003;21:1948-51.
37. Uzunalimoglu O, Yurdaydin C, Cetinkaya H, Bozkaya H, Sahin T, Colakoglu S, Tankurt E, Sarioglu M, ozenirler S, Akkiz H, Tozun N,
Degertekin H, Okten A. Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci 2001;46:1022-8.
38. Qirbi N, Hall AJ. Epidemiology of hepatitis B virus infection in the Middle East. East Mediterr Health J 2001;7:1034-45.
39. Allison RD, Teleb N, Al Awaidy S, Ashmony H, Alexander JP, Patel MK. Hepatitis B control among children in the Eastern
Mediterranean region of the World Health Organization. Vaccine 2016:534;2403-9.
40. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a
systematic review of data published between 1965 and 2013. Lancet 2015;386:1546-55.
41. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden
and vaccination impact. Int J Epidemiology 2005;34:1329-39.
42. Alavian SM, Haghbin H. Relative importance of hepatitis B and C viruses in hepatocellular carcinoma in EMRO countries and the
Middle East: a systematic review. Hepat Mon 2016;16:e35106.
43. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Yang SS, Kuo HS, Chen DS. Decreased incidence of
hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009;101:1348-55.
44. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-
specific antibody to HCV seroprevalence. Hepatology 2013;57:1333-42.
45. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date
of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol 2016;22:7824-40.
46. Bruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU. Hepatitis C virus genotype 1b as a major risk factor associated
with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 2007;46:1350-6.
47. Kanwal F, Kramer JR, Ilyas J, Duan Z, El-Serag H. HCV Genotype 3 is associated with an increased risk of cirrhosis and hepatocellular
carcinoma in a national samples of US Veterans with HCV. Hepatology 2014;60:98-105.
48. Petruzziello A, Samantha Marigliano S, Loquercio G, Coppola N, Piccirillo M, Leongito M, Azzaro R, Izzo F, Botti G. Hepatitis C
Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study. Infect
Agent Cancer 2017;12:52.
49. Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbiol 2010;36:91-133.
50. Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. Hepatitis C virus genotype Ib is a risk factor for hepatocellular carcinoma
development: a meta-analysis. J Hepatol 2009;50:1142-54.
51. Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag
JL, Ghany MG, Morishima C, Goodman ZD. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related
advanced liver disease. Gastroenterology 2009;136:138-48.
52. Mahale P, Torres HA, Kramer JR, Hwang LY, Li R, Brown LEL, Engels EA. Hepatitis C virus infection and the risk of cancer among
elderly US adults: a registry-based case-control study. Cancer 2017;123:1202-11.
53. The growing threats of hepatitis B and C in the Eastern Mediterranean Region: a call for action. Technical paper presented at the 56th
Regional Committee for the Eastern Mediterranean, August 2009. Avaiable from: http://applications.emro.who.int/docs/EM_RC56_3_
en.pdf [Last accessed on 22 Jun 2018].
54. Mohamed MK, Bakr I, El-Hosiyny M, Arafa N, Hassan A, Ismail S, Anwar M, Attala M, Rekacewicz C, Zalata K, Abdel-Hamid M,
Esmat G, Fontanet A. HCV-related morbidity in a rural community of Egypt. J Med Virol 2006;78:1185-9.